This, in turn, should lead to an imbalance in the Mdm2-p53 network, the role of which in the progression of many types of tumors, including CRC, is well known [60,61,62], and, consequently, to the activation of some genes of the p53 pathway and the induction of cellular senescence. The gene discussed is TP53; the disease is colorectal carcinoma.